文献速递妇产影像介入技术与安全MR

利用影像组学预测子宫腺肌病磁共振引导聚焦超声消融治疗的长期结局

Utilization of radiomics to predict long-term outcome of magnetic resonance-guided focused ultrasound ablation therapy in adenomyosis.
PubMed 文献 · Eur Radiol · 2020-07-28

回顾性分析69例子宫腺肌病患者MRgFUS术前T2WI影像组学特征与临床参数,构建影像组学-临床联合模型预测治疗反应。测试队列AUC为0.81(95%CI 0.592-0.975),决策曲线分析显示良好性能。结论认为该模型可辅助放射科医生评估患者能否获得良好反应。

要点

  • MRgFUS术后约三分之一患者6个月仍有症状,术前预测反应有助于筛选患者。
  • T2WI影像组学联合临床参数模型在测试队列预测 poor response 的AUC为0.81(95%CI 0.592-0.975)。
  • 影像组学模型包含4个T2WI特征,联合8个临床特征可进一步提升预测能力。

核心结论

  • 由T2WI影像组学特征和临床参数构成的预测模型可用于指导放射科医生评估子宫腺肌病患者MRgFUS治疗后是否获得良好反应。

研究设计与样本

  • 回顾性研究,纳入69例子宫腺肌病接受MRgFUS治疗的患者(平均年龄38.6岁,年龄范围26-50岁),分为训练队列48例和测试队列21例。
  • 构建机器学习模型比较临床模型、影像组学模型和影像组学-临床联合模型(结合筛选后的影像组学特征与临床参数),用bootstrap获得模型区分度结果,并在训练和测试队列中行ROC曲线、AUC和决策曲线分析。

关键影像表现/征象

  • 影像组学模型包含4个筛选出的特征,对患者MRgFUS治疗反应不佳表现出一定预测能力。
  • 影像组学-临床联合模型显示良好区分度,测试队列AUC为0.81(95%CI 0.592-0.975)。

诊断标准与关键数值

  • 影像组学-临床联合模型在测试队列的AUC为0.81(95%CI 0.592-0.975)。
  • 影像组学模型由4个T2WI影像组学特征构成,联合模型结合4个影像组学特征与8个临床特征。

临床应用与阅片要点

  • 基于T2WI的影像组学特征联合临床参数有助于预测子宫腺肌病患者对MRgFUS治疗是否可能获得良好反应。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To develop and evaluate a T2 MR-based radiomics prediction model incorporating radiomics features and clinical parameters to predict the response to magnetic resonance-guided focused ultrasound surgery (MRgFUS) in patients with adenomyosis.

MATERIALS AND METHODS: Sixty-nine patients (mean age, 38.6 years; age range, 26-50 years) with adenomyosis treated by MRgFUS were reviewed and allocated to training (n = 48) and testing cohorts (n = 21). One thousand one hundred eighteen radiomics features were extracted from T2-weighted imaging before MRgFUS. The radiomics features' dimension was reduced by Pearson correlation coefficient after normalization. Analysis of variance and logistical regression were used for feature selection by fivefold cross-validation in the training cohort, and the machine learning model was constructed for comparing the clinical model, radiomics model, and radiomics-clinical model which combined survived radiomics features and clinical parameters. The discrimination result of the model was obtained by bootstrap; receiver operating characteristic curve, area under the curve (AUC), and decision curve analyses were performed to illustrate the model performance in both the training and testing cohorts.

RESULTS: Good response was achieved in 47 patients (68.1%) and failed in 22 patients (38.9%). The radiomics model comprised four selected features and demonstrated a degree of prediction capability of patients' poor response to MRgFUS treatment. The radiomics-clinical model showed good discrimination, with an AUC of 0.81 (95% confidence interval, 0.592-0.975) in the testing cohort. The decision curve analysis also showed favorable performance of the radiomics-clinical model.

CONCLUSIONS: A prediction model composed of T2WI-based radiomics features and clinical parameters could be applied to guide the radiologist to evaluate MRgFUS for patients with adenomyosis who will achieve good response.

KEY POINTS: • Magnetic resonance imaging-guided focused ultrasound surgery represents an alternative treatment for adenomyosis, but nearly one third of patients remain symptomatic 6 months after MRgFUS. • Combining four radiomics features of T2-weighted MRI with eight clinical features further improves prediction of poor responders to MR-guided focused ultrasound treatment of uterine adenomyosis (AUC = 0.81 in the testing cohort). • The radiomics model based on T2-weighted imaging combined with clinical parameters can help predict which patients are likely to have a good response to MRgFUS for adenomyosis.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Li Z, Zhang J, Song Y, et al. Utilization of radiomics to predict long-term outcome of magnetic resonance-guided focused ultrasound ablation therapy in adenomyosis. Eur Radiol. 2020. PMID: 32725335. doi:10.1007/s00330-020-07076-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。